1. Academic Validation
  2. Design, synthesis, and structure-activity relationship study of halogen containing 2-benzylidene-1-indanone derivatives for inhibition of LPS-stimulated ROS production in RAW 264.7 macrophages

Design, synthesis, and structure-activity relationship study of halogen containing 2-benzylidene-1-indanone derivatives for inhibition of LPS-stimulated ROS production in RAW 264.7 macrophages

  • Eur J Med Chem. 2017 Jun 16:133:121-138. doi: 10.1016/j.ejmech.2017.03.049.
Aarajana Shrestha 1 Hye Jin Oh 1 Mi Jin Kim 1 Nirmala Tilija Pun 1 Til Bahadur Thapa Magar 1 Ganesh Bist 1 Hongseok Choi 1 Pil-Hoon Park 2 Eung-Seok Lee 3
Affiliations

Affiliations

  • 1 College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
  • 2 College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea. Electronic address: parkp@yu.ac.kr.
  • 3 College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea. Electronic address: eslee@yu.ac.kr.
Abstract

As a continuous effort to discover new potential anti-inflammatory agents, we systematically designed and synthesized sixty-one 2-benzylidene-1-indanone derivatives with structural modification of chalcone, and evaluated their inhibitory activity on LPS-stimulated ROS production in RAW 264.7 macrophages. Systematic structure-activity relationship study revealed that hydroxyl group in C-5, C-6, or C-7 position of indanone moiety, and ortho-, meta-, or para-fluorine, trifluoromethyl, trifluoromethoxy, and bromine functionalities in phenyl ring are important for inhibition of ROS production in LPS-stimulated RAW 264.7 macrophages. Among all the tested compounds, 6-hydroxy-2-(2-(trifluoromethoxy) benzylidene)-2,3-dihydro-1H-inden-1-one (compound 44) showed the strongest inhibitory activity of ROS production. Further studies on the mode of action revealed that compound 44 potently suppressed LPS-stimulated ROS production via modulation of NADPH Oxidase. The findings of this work could be useful to design 2-benzylidene-indanone based lead compounds as novel anti-inflammatory agents.

Keywords

Anti-inflammatory agents; Halogen containing 2-benzylidene-1-indanone; Inhibition of ROS production; RAW 264.7 macrophages; Structure-activity relationship.

Figures